Court Axes Lawsuit Claiming Insufficient Warning of Heart Attack Risk From GSK Drug

Drug Industry Daily
A A
A federal judge threw out a case against GlaxoSmithKline that was part of multidistrict litigation over the labeling of its diabetes drug Avandia.

To View This Article:

Login

Subscribe To Drug Industry Daily